0001438133-22-000134.txt : 20220527 0001438133-22-000134.hdr.sgml : 20220527 20220527215150 ACCESSION NUMBER: 0001438133-22-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220525 FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANSEN BRIAN B CENTRAL INDEX KEY: 0001542377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 22980185 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_165370269008360.xml FORM 4 X0306 4 2022-05-25 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001542377 HANSEN BRIAN B C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP & CHIEF COMMERCIAL OFFICER Common Stock 7552 D Restricted Stock Unit 2022-05-25 4 A 0 5691 0 A Common Stock 5691.0 5691 D Performance Stock Unit 2022-05-25 4 A 0 5523 0 A Common Stock 5523.0 5523 D Stock Option 65.28 2022-05-25 4 A 0 8544 0 A Common Stock 8544.0 8544 D Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the2013 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. The option shall vest as to thirty-three percent (33%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in twenty-four (24) equal monthly installments thereafter, subject to the terms of the 2013 Plan. The expiration date for these options is 10 years from the date of grant. s/ Rachel Malina, Attorney-in-Fact for Brian B. Hansen 2022-05-27